Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions

• Hauptverfasser: Meera Varshneya (Verfasst von), Itziar Irurzun-Arana (Verfasst von), Chiara Campana (Verfasst von), Rafael Dariolli (Verfasst von), Amy Gutierrez (Verfasst von), Taylor K. Pullinger (Verfasst von), Eric A. Sobie (Verfasst von)
• Format: Buch
• Veröffentlicht: Wiley, 2021-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Many drugs that have been proposed for treatment of coronavirus disease 2019 (COVID‐19) are reported to cause cardiac adverse events, including ventricular arrhythmias. In order to properly weigh risks against potential benefits, particularly when decisions must be made quickly, mathematical modelin...